Elaine Tanhehco to Ventricular Dysfunction, Left
This is a "connection" page, showing publications Elaine Tanhehco has written about Ventricular Dysfunction, Left.
Connection Strength
0.240
-
Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure. J Heart Lung Transplant. 2005 Oct; 24(10):1619-25.
Score: 0.051
-
Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure. Br J Pharmacol. 2003 Jan; 138(2):301-9.
Score: 0.042
-
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation. 2002 Dec 03; 106(23):2967-72.
Score: 0.042
-
Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Cardiovasc Drugs Ther. 2002 Sep; 16(5):443-9.
Score: 0.041
-
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure. Cardiovasc Drugs Ther. 2002 May; 16(3):209-14.
Score: 0.040
-
Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res. 2003 Nov 28; 93(11):1095-101.
Score: 0.011
-
Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail. 2003 Feb; 9(1):69-75.
Score: 0.011